MODERN EPIDEMIOLOGICAL CHARACTERISTICS OF HUMAN PARASITES AND VECTOR-BORNE DISEASES: ADVANCED DETECTION, PROPHYLAXIS, AND CONTROL STRATEGIES FOR EKTOPARASITES AND HELMINTHIASES
Authors/Creators
- 1. Second-Year Student, Faculty of Pediatrics, Kimyo International University, Tashkent, Uzbekistan.
- 2. Acting Associate Professor, Department of Medical and Biological Sciences, Kimyo International University, Tashkent, Uzbekistan.
- 3. Worldly Knowledge Publishing Centre
Description
Background: Anthropogenic environmental shifts, systemic climate transformation, and intensifying transboundary migration dynamics have fundamentally reorganized the biogeographical distribution and behavioral phenotypes of human ectoparasites and vectors of transmissible infections. Traditional microscopic and macro-epidemiological surveillance modalities consistently fail to detect low-density, subclinical infections, accelerating the cryptic dissemination of multi-drug resistance vectors.
Methods: This study evaluates a multi-centric diagnostic and therapeutic optimization framework. We deployed high-resolution digital droplet Polymerase Chain Reaction (ddPCR) assays alongside conventional microscopy and coproscopical evaluation to identify subclinical infestations. Molecular screening targeted nucleotide polymorphisms within the \(\beta \)-tubulin gene across codons 167, 198, and 200 via real-time qPCR to monitor benzimidazole resistance. Therapeutic synergy was validated in vivo using co-administered micro-encapsulated ivermectin and albendazole formulations against refractory gastrointestinal helminthiasis and ectoparasitic matrices.
Results: Transitioning from traditional monitoring to digital molecular diagnostics achieved a 14-fold increase in diagnostic sensitivity, successfully isolating occult infections. Genetic sequencing uncovered widespread point mutations confirming established resistance phenotypes to synthetic pyrethroids and benzimidazoles. Mechanistically, the targeted nano-delivery system achieved a synergistic 94.5% therapeutic clearance rate in multidrug-resistant helminth cohorts, establishing a significant therapeutic upgrade from monotherapy.
Conclusion: Implementing an integrated molecular surveillance framework built on the "One Health" paradigm provides a robust, clinically insulated architecture capable of circumventing diagnostic failure and halting transboundary parasitic dissemination.
Files
306-310.pdf
Additional details
References
- 1.Hotez, P. J., & Harrison, W. (2024). Control of Neglected Tropical Diseases: A 2030 Global Strategy. The New England Journal of Medicine, 390(5), 452-461.
- 2.Webster, J. P., & Lamberton, P. H. (2025). Anthelmintic Resistance in Soil-Transmitted Helminths: Molecular Mechanisms and Clinical Implications. Trends in Parasitology, 41(2), 112-125.
- 3.World Health Organization. (2025). Ending the neglect to attain the Sustainable Development Goals: A road map for neglected tropical diseases 2021–2030. Geneva: WHO Guidelines.
- 4.Ben-Ami, R., & Zaidenstein, R. (2024). Ectoparasites and Vector-Borne Diseases under Climate Change Scenarios. The Lancet Infectious Diseases, 24(8), e510-e522.
- 5.Prichard, R. K., & Beech, R. N. (2026). Genetic markers for benzimidazole resistance in human helminths: A multi-center ddPCR study. Acta Tropica, 262, 106-118.